CPHA Canvax

"The most substantial effects of the coronavirus disease 2019 (COVID-19) pandemic on children have related more to disruptions in educational, physical, and social activities than direct viral effects. Nonetheless, there have been small numbers of cases of severe COVID-19 and COVID-19-associated multisystem inflammatory syndrome that have caused significant direct morbidity. With the arrival of the more transmissible Delta variant of the SARS-CoV-2 virus, more children are becoming infected and consequently, the numbers of children with severe disease are increasing. Vaccination against COVID-19 is now available in Canada for children and adolescents aged 12 years and over. The Canadian Paediatric Society advocates for the vaccination of all children and adolescents aged 12 years and over." - Canadian Paediatric Society

Web link

COVID-19 vaccine for children

Related Resources





Vaccine Safety and Development,Vaccine Safety,Vaccine Safety,Adverse Events Following Immunization (AEFI),Research and Development,Vaccine Effectiveness and Efficacy,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and Development
Vaccine Safety
Vaccine Safety
Adverse Events Following Immunization (AEFI)
Research and Development
Vaccine Effectiveness and Efficacy
Monitoring and Surveillance
Outbreaks and Pandemics


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.